跳至主要内容
临床试验/ISRCTN96459690
ISRCTN96459690已完成未知

Incorporation of omega-3 fatty acids in healthy humans following oral dosing of dietary supplements

Pronova BioPharma0 个研究点目标入组 80 人开始时间: 2017年2月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
80

研究概览

简要总结

2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30203029 results

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Healthy males and females
  • 2. Age 18 to 65 years
  • 3. Body mass index 20 to 35 kg/m2
  • 4. Not consuming fish oil or similar supplements
  • 5. Not eating more than one oily fish meal per week
  • 6. Willing to adhere to the study protocol
  • 7. Being able to provide written informed consent
  • 8. Omega-3 index (EPA+DHA in red blood cells_ < 6.5 at screening

排除标准

  • 1. Being diabetic (type 1 or type 2)
  • 2. Being vegetarian or vegan and unwilling to consume capsules with a beef gelatine coating
  • 3. Use of prescribed medicine to control inflammation
  • 4. Smokers
  • 5. Chronic gastrointestinal problems (e.g. IBD, IBS, celiac disease, cancer)
  • 6. Allergic to fish
  • 7. Allergic to soybean
  • 8. Participation in another clinical trial (currently or in the 12 weeks prior to study entry)
  • 9. Pregnancy or lactation
  • 10. Blood donations during 3 months prior to or during the study period
  • 11. Omega-3 index (EPA+DHA in red blood cells > 6.5 at screening

研究者

发起方
Pronova BioPharma

相似试验

Incorporation of omega-3 fatty acids in healthy... | 临床试验